Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas

Christopher S. Gondi, Sajani S. Lakka, Niranjan Yanamandra, William C. Olivero, Dzung H. Dinh, Meena Gujrati, C. H. Tung, Ralph Weissleder, Jasti S. Rao

Research output: Contribution to journalArticle

Abstract

We have shown previously that urokinase plasminogen activator receptor (uPAR) and cathepsin B are overexpressed during glioma progression, particularly at the leading edge of the tumor. In the present study, we simultaneously down-regulated uPAR and cathepsin B in SNB19 glioma cell monolayer or SNB19 spheroids using an adenoviral vector carrying antisense uPAR and antisense cathepsin B and a combination of these genes as determined by Western blot analysis. The Ad-uPAR-Cath B-infected cells revealed a marked reduction in tumor growth and invasiveness as compared with the parental and vector controls. In vitro and in vivo angiogenic assays demonstrated inhibition of capillary-like structure formation and microvessel formation after Ad-uPAR-Cath B infection of SNB19 cells when compared with Ad-cytomegalovirus (CMV)-infected or mock-infected controls. Furthermore, using a near infrared fluorescence probe, in vivo imaging for cathepsin B indicated low/undetectable levels of fluorescence after injection of the Ad-uPAR-Cath B construct into preestablished s.c. tumors as compared with Ad-CMV-treated and untreated tumors. The effect with bicistronic construct (Ad-uPAR-Cath B) was much higher than with single (Ad-uPAR/Ad-Cath B) constructs. These results indicate that the down-regulation of cathepsin B and uPAR plays a significant role in inhibiting tumor growth, invasion, and angiogenesis. Hence, the targeting of these two proteases may be a potential therapy for brain tumors and other cancers.

Original languageEnglish (US)
Pages (from-to)4069-4077
Number of pages9
JournalCancer Research
Volume64
Issue number12
DOIs
StatePublished - Jun 15 2004

Fingerprint

Urokinase Plasminogen Activator Receptors
Cathepsin B
Adenoviridae
Glioma
Growth
Neoplasms
Cytomegalovirus
Fluorescence
Microvessels
Brain Neoplasms
Peptide Hydrolases
Down-Regulation
Western Blotting

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas. / Gondi, Christopher S.; Lakka, Sajani S.; Yanamandra, Niranjan; Olivero, William C.; Dinh, Dzung H.; Gujrati, Meena; Tung, C. H.; Weissleder, Ralph; Rao, Jasti S.

In: Cancer Research, Vol. 64, No. 12, 15.06.2004, p. 4069-4077.

Research output: Contribution to journalArticle

Gondi, Christopher S. ; Lakka, Sajani S. ; Yanamandra, Niranjan ; Olivero, William C. ; Dinh, Dzung H. ; Gujrati, Meena ; Tung, C. H. ; Weissleder, Ralph ; Rao, Jasti S. / Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas. In: Cancer Research. 2004 ; Vol. 64, No. 12. pp. 4069-4077.
@article{96fdab7df5604d1994c236e0ff2c99d3,
title = "Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas",
abstract = "We have shown previously that urokinase plasminogen activator receptor (uPAR) and cathepsin B are overexpressed during glioma progression, particularly at the leading edge of the tumor. In the present study, we simultaneously down-regulated uPAR and cathepsin B in SNB19 glioma cell monolayer or SNB19 spheroids using an adenoviral vector carrying antisense uPAR and antisense cathepsin B and a combination of these genes as determined by Western blot analysis. The Ad-uPAR-Cath B-infected cells revealed a marked reduction in tumor growth and invasiveness as compared with the parental and vector controls. In vitro and in vivo angiogenic assays demonstrated inhibition of capillary-like structure formation and microvessel formation after Ad-uPAR-Cath B infection of SNB19 cells when compared with Ad-cytomegalovirus (CMV)-infected or mock-infected controls. Furthermore, using a near infrared fluorescence probe, in vivo imaging for cathepsin B indicated low/undetectable levels of fluorescence after injection of the Ad-uPAR-Cath B construct into preestablished s.c. tumors as compared with Ad-CMV-treated and untreated tumors. The effect with bicistronic construct (Ad-uPAR-Cath B) was much higher than with single (Ad-uPAR/Ad-Cath B) constructs. These results indicate that the down-regulation of cathepsin B and uPAR plays a significant role in inhibiting tumor growth, invasion, and angiogenesis. Hence, the targeting of these two proteases may be a potential therapy for brain tumors and other cancers.",
author = "Gondi, {Christopher S.} and Lakka, {Sajani S.} and Niranjan Yanamandra and Olivero, {William C.} and Dinh, {Dzung H.} and Meena Gujrati and Tung, {C. H.} and Ralph Weissleder and Rao, {Jasti S.}",
year = "2004",
month = "6",
day = "15",
doi = "10.1158/0008-5472.CAN-04-1243",
language = "English (US)",
volume = "64",
pages = "4069--4077",
journal = "Cancer Research",
issn = "0008-5472",
number = "12",

}

TY - JOUR

T1 - Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas

AU - Gondi, Christopher S.

AU - Lakka, Sajani S.

AU - Yanamandra, Niranjan

AU - Olivero, William C.

AU - Dinh, Dzung H.

AU - Gujrati, Meena

AU - Tung, C. H.

AU - Weissleder, Ralph

AU - Rao, Jasti S.

PY - 2004/6/15

Y1 - 2004/6/15

N2 - We have shown previously that urokinase plasminogen activator receptor (uPAR) and cathepsin B are overexpressed during glioma progression, particularly at the leading edge of the tumor. In the present study, we simultaneously down-regulated uPAR and cathepsin B in SNB19 glioma cell monolayer or SNB19 spheroids using an adenoviral vector carrying antisense uPAR and antisense cathepsin B and a combination of these genes as determined by Western blot analysis. The Ad-uPAR-Cath B-infected cells revealed a marked reduction in tumor growth and invasiveness as compared with the parental and vector controls. In vitro and in vivo angiogenic assays demonstrated inhibition of capillary-like structure formation and microvessel formation after Ad-uPAR-Cath B infection of SNB19 cells when compared with Ad-cytomegalovirus (CMV)-infected or mock-infected controls. Furthermore, using a near infrared fluorescence probe, in vivo imaging for cathepsin B indicated low/undetectable levels of fluorescence after injection of the Ad-uPAR-Cath B construct into preestablished s.c. tumors as compared with Ad-CMV-treated and untreated tumors. The effect with bicistronic construct (Ad-uPAR-Cath B) was much higher than with single (Ad-uPAR/Ad-Cath B) constructs. These results indicate that the down-regulation of cathepsin B and uPAR plays a significant role in inhibiting tumor growth, invasion, and angiogenesis. Hence, the targeting of these two proteases may be a potential therapy for brain tumors and other cancers.

AB - We have shown previously that urokinase plasminogen activator receptor (uPAR) and cathepsin B are overexpressed during glioma progression, particularly at the leading edge of the tumor. In the present study, we simultaneously down-regulated uPAR and cathepsin B in SNB19 glioma cell monolayer or SNB19 spheroids using an adenoviral vector carrying antisense uPAR and antisense cathepsin B and a combination of these genes as determined by Western blot analysis. The Ad-uPAR-Cath B-infected cells revealed a marked reduction in tumor growth and invasiveness as compared with the parental and vector controls. In vitro and in vivo angiogenic assays demonstrated inhibition of capillary-like structure formation and microvessel formation after Ad-uPAR-Cath B infection of SNB19 cells when compared with Ad-cytomegalovirus (CMV)-infected or mock-infected controls. Furthermore, using a near infrared fluorescence probe, in vivo imaging for cathepsin B indicated low/undetectable levels of fluorescence after injection of the Ad-uPAR-Cath B construct into preestablished s.c. tumors as compared with Ad-CMV-treated and untreated tumors. The effect with bicistronic construct (Ad-uPAR-Cath B) was much higher than with single (Ad-uPAR/Ad-Cath B) constructs. These results indicate that the down-regulation of cathepsin B and uPAR plays a significant role in inhibiting tumor growth, invasion, and angiogenesis. Hence, the targeting of these two proteases may be a potential therapy for brain tumors and other cancers.

UR - http://www.scopus.com/inward/record.url?scp=3042551389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042551389&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-04-1243

DO - 10.1158/0008-5472.CAN-04-1243

M3 - Article

VL - 64

SP - 4069

EP - 4077

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 12

ER -